DRG International, Inc. A BioCheck Company

DRG International, Inc., a BioCheck Company, is a global manufacturer and distributor specializing in clinical diagnostic and research immunoassays, particularly ELISAs (enzyme-linked immunosorbent assays). Founded in 1970 and headquartered in Springfield, New Jersey, DRG operates in over 110 countries, providing innovative solutions in specialty clinical diagnostics and medical equipment. The company offers a comprehensive range of ELISA kits for various medical fields, including tumor markers, cardiac markers, and infectious diseases. DRG also produces the DRG:HYBRiD-XL®, a fully automated analyzer designed for immunoassays and clinical chemistry testing, enhancing laboratory efficiency. Following its acquisition by BioCheck, Inc. in August 2021, DRG has expanded its capabilities in assay development and manufacturing, particularly for in vitro diagnostic tests. Both companies maintain high-quality standards, ensuring compliance with international medical device regulations.

• Employees 35
• Founded 1970
• Annual Revenue $10000000